Multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome

Current Urology Reports

Volumn 6, Issue 4, 2005, Pages 296-299

  Shoskes, Daniel A ^a   Katz, Erin ^b  

^a DEPARTMENT OF COLORECTAL SURGERY   (United States)

^b NONE

Author keywords

Finasteride; Multimodal Therapy; Prostatitis; Quercetin; Tamsulosin

Indexed keywords

ANTIINFECTIVE AGENT;

CHRONIC DISEASE; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; PELVIS PAIN SYNDROME; PHYSIOTHERAPY; PHYTOTHERAPY; PROSTATITIS; REVIEW; SYNDROME;

ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; COMBINED MODALITY THERAPY; HUMANS; MALE; PELVIC PAIN; PHYSICAL THERAPY MODALITIES; PHYTOTHERAPY; PROSTATITIS; SYNDROME;

EID: 27744483542     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-005-0027-0     Document Type: Article

References (31)

1. Pontari M, Ruggieri M: Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol 2004, 172:839–845. Excellent review of the possible etiologies of CPPS. DOI: 10.1097/01.ju.0000136002.76898.04
2. Shoskes DA: Use of antibiotics in chronic prostatitis syndromes. Can J Urol 2001, 8(suppl 1):24–28.
3. Luzzi G: Chronic prostatitis and chronic pelvic pain in men: aetiology, diagnosis, and management. J Eur Acad Dermatol Venereol 2002, 16:253–256. DOI: 10.1046/j.1468-3083.2002.00481.x
4. Shoskes DA: Phytotherapy in chronic prostatitis. Urology 2002, 60:35–37. DOI: 10.1016/S0090-4295(02)02383-X
5. Cheah P, Liong M, Yuen K, et al.: Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo-controlled trial. J Urol 2003, 169:592–596. DOI: 10.1016/S0022-5347(05)63960-2
6. Shoskes D, Zeitlin S: Use of prostatic massage in combination with antibiotics in the treatment of chronic prostatitis. Prostate Cancer Prostatic Dis 1999, 2:159–162. DOI: 10.1038/sj.pcan.4500308
7. Nickel J, Downey J, Pontari M, et al.: A randomized, placebocontrolled, multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis). BJU Int 2004, 93:991–995. DOI: 10.1111/j.1464-410X.2003.04766.x
8. Nickel J, Downey J, Ardern D, et al.: Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome. J Urol 2004, 172:551–554. DOI: 10.1097/01.ju.0000131592.98562.16
9. Shoskes D, Hakim L, Ghoniem G, Jackson C: Long-term results of multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome. J Urol 2003, 169:1406–1410. Only study to look directly at multimodal therapy in CPPS. DOI: 10.1097/01.ju.0000055549.95490.3c
10. Bjerklund Johansen TE, Gruneberg RN, Guibert J, et al.:The role of antibiotics in the treatment of chronic prostatitis: a consensus statement. Eur Urol 1998, 34:457–466. DOI: 10.1159/000019784
11. Weidner W, Ludwig M, Brahler E, Schiefer HG: Outcome of antibiotic therapy with ciprofloxacin in chronic bacterial prostatitis. Drugs 1999, 58:103–106. DOI: 10.2165/00003495-199958002-00021
12. Barbalias GA, Nikiforidis G, Liatsikos EN: Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics. J Urol 1998, 159:883–887. DOI: 10.1016/S0022-5347(01)63761-3
13. Nickel JC, Alexander R, Anderson R, et al.: Prostatitis unplugged? Prostatic massage revisited. Tech Urol 1999, 5:1–7.
14. Mayersak J: Transrectal ultrasonography directed intraprostatic injection of gentamycin-xylocaine in the management of the benign painful prostate syndrome: a report of a 5-year clinical study of 75 patients. Int Surg 1998, 83:347–349.
15. Dale A, Wilson J, Forster G, et al.: Management of chronic prostatitis in genitourinary medicine clinics in the United Kingdom’s North Thames Region: 2000. Int J STD AIDS 2001, 12:256–259. DOI: 10.1258/0956462011923011
16. Nickel JC, Downey J, Johnston B, et al.: Predictors of patient response to antibiotic therapy for the chronic prostatitis/ chronic pelvic pain syndrome: a prospective, multicenter clinical trial. J Urol 2001, 165:1539–1544. DOI: 10.1016/S0022-5347(05)66344-6
17. Nickel JC, Downey J, Clark J, Group TCPR: Levofloxacin treatment for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized, placebo-controlled, multicenter trial. J Urol 2003, 169:27. DOI: 10.1097/01.ju.0000054983.45096.16
18. Alexander R, Propert K, Schaeffer A, et al.: Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med 2004, 141:581–589. Key NIH study showing that typical long-standing prostatitis patients do not respond to 6 weeks of therapy with antibiotics or á blockers.
19. Nickel JC, Downey J, Feliciano AE Jr, Hennenfent B: Repetitive prostatic massage therapy for chronic refractory prostatitis: the Philippine experience. Tech Urol 1999, 5:146–151.
20. Kajander E, Ciftcioglu N, Aho K, Garcia-Cuerpo E: Characteristics of nanobacteria and their possible role in stone formation. Urol Res 2003, 31:47–54.
21. Miller V, Rodgers G, Charlesworth J, et al.: Evidence of Nanobacterial-like structures in human calcified arteries and cardiac valves. Am J Physiol Heart Circ Physiol 2004, 287:H1115-H1124. DOI: 10.1152/ajpheart.00075.2004
22. Khullar M, Sharma S, Singh S, et al.: Morphological and immunological characteristics of nanobacteria from human renal stones of a north Indian population. Urol Res 2004, 32:190–195. DOI: 10.1007/s00240-004-0400-3
23. Geramoutsos I, Gyftopoulos K, Perimenis P, et al.: Clinical correlation of prostatic lithiasis with chronic pelvic pain syndromes in young adults. Eur Urol 2004, 45:333–338. DOI: 10.1016/j.eururo.2003.09.020
24. Ciftcioglu N, Miller-Hjelle MA, Hjelle J, Kajander E: Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method. Antimicrob Agents Chemother 2002, 46:2077–2086. DOI: 10.1128/AAC.46.7.2077-2086.2002
25. Maniscalco B, Taylor K: Calcification in coronary artery disease can be reversed by EDTA-tetracycline long-term chemotherapy. Pathophysiology 2004, 11:95–101. DOI: 10.1016/j.pathophys.2004.06.001
26. Shoskes DA, Thomas K, Gomez E: Antinanobacterial therapy in men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience. J Urol, in press.
27. Shoskes DA, Zeitlin SI, Shahed A, Rajfer J: Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 1999, 54:960–963. DOI: 10.1016/S0090-4295(99)00358-1
28. Chen ZY, Chan PT, Ho KY, et al.: Antioxidant activity of natural flavonoids is governed by number and location of their aromatic hydroxyl groups. Chem Phys Lipids 1996, 79:157–163. DOI: 10.1016/0009-3084(96)02523-6
29. Hellstrom WJ, Schmidt RA, Lue TF, Tanagho EA: Neuromuscular dysfunction in nonbacterial prostatitis. Urology 1987, 30:183–188. DOI: 10.1016/0090-4295(87)90193-2
30. Ye Z, Cai D, Lan R, et al.: Biofeedback therapy for chronic pelvic pain syndrome. Asian J Androl 2003, 5:155–158.
31. Chen R, Nickel J: Acupuncture ameliorates symptoms in men with chronic prostatitis/chronic pelvic pain syndrome. Urology 2003, 61:1156–1159. DOI: 10.1016/S0090-4295(03)00141-9